HEATHER MELTON: Open Payments
NPI 1669807830 · WOODBURY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 86 payments from 22 companies in 2025. Trend: 2023 $1,358 · 2024 $1,391 · 2025 $1,708
Food & beverage: $1,708
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $332 |
| ABBVIE INC. | 10 | $281 |
| Axsome Therapeutics, Inc. | 10 | $187 |
| Novo Nordisk Inc | 12 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Alkermes, Inc. | 2 | $50 |
| Mannkind Corporation | 3 | $48 |
Products named: REXULTI, VRAYLAR, Auvelity, Ozempic, CAPLYTA, Kerendia, RECORLEV, XIFAXAN.
Industry payments across TN — which companies pay providers there.
